American Journal of Cardiology
Volume 88, Issue 10 , Pages 1143-1146, 15 November 2001

Frequency of serum low-density lipoprotein cholesterol measurement and frequency of results ≤100 mg/dl among patients who had coronary events (Northwest VA Network Study)

  • Kevin L Sloan, MD

      Affiliations

    • Corresponding Author InformationAddress for reprints: Kevin L. Sloan, MD, VA Puget Sound Health Care System (116-DDTP), Seattle, Washington 98108.
    • Mental Health Service, VA Puget Sound Health Care System, Seattle, Washington, USA
    • Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, USA
  • ,
  • Anne E Sales, MSN, PhD

      Affiliations

    • Health Services Research and Development Service, VA Puget Sound Health Care System, Seattle, Washington, USA
    • Department of Health Services, University of Washington, Seattle, Washington, USA
  • ,
  • James P Willems, MD

      Affiliations

    • Health Services Research and Development Service, VA Puget Sound Health Care System, Seattle, Washington, USA
    • Robert Wood Johnson Clinical Scholars Program, Seattle, Washington, USA
  • ,
  • Nathan R Every, MD

      Affiliations

    • Division of Cardiology, VA Puget Sound Health Care System, Seattle, Washington, USA
  • ,
  • Gary V Martin, MD

      Affiliations

    • Division of Cardiology, VA Puget Sound Health Care System, Seattle, Washington, USA
  • ,
  • Haili Sun, PhD

      Affiliations

    • Health Services Research and Development Service, VA Puget Sound Health Care System, Seattle, Washington, USA
  • ,
  • Sandra Pineros, MPH

      Affiliations

    • Health Services Research and Development Service, VA Puget Sound Health Care System, Seattle, Washington, USA
  • ,
  • Nancy Sharp, PhD

      Affiliations

    • Health Services Research and Development Service, VA Puget Sound Health Care System, Seattle, Washington, USA

Received 25 June 2001; received in revised form 18 July 2001; accepted 18 July 2001.

Abstract 

This population-based, cross-sectional analysis targeted all veterans with coronary heart disease (CHD) who were active patients in primary care or cardiology clinics in the Veterans Health Administration Northwest Network from July 1998 to June 1999. We report guideline compliance rates, including whether low-density lipoprotein (LDL) was measured, and if measured, whether the LDL was ≤100 mg/dl. In addition, we utilized multivariate logistic regression to determine patient characteristics associated with LDL measurements and levels. Of 13,891 active patients with CHD, 5,552 (40.0%) did not have a current LDL measurement. Of those with LDL measurements, 39.1% were at the LDL goal of ≤100 mg/dl, whereas 26.5% had LDL ≥130 mg/dl. Male gender, younger age, history of angioplasty or coronary artery bypass grafting, current hypertension, diabetes mellitus, and angina pectoris were associated with increased likelihood of LDL measurement. Older age and current diabetes and angina were associated with increased likelihood of LDL being ≤100 mg/dl, if measured. Although these rates of guideline adherence in the CHD population compare well to previously published results, they continue to be unacceptably low for optimal clinical outcomes. Attention to both LDL measurement and treatment (if elevated) is warranted.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 
  •  The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs.

 This study was supported by the Veterans Health Administration, Health Services Research and Development Service, Project # IHS 99233-1, Washington, DC; and by Merck & Co., Inc., Whitehouse Station, New Jersey.

PII: S0002-9149(01)02050-1

American Journal of Cardiology
Volume 88, Issue 10 , Pages 1143-1146, 15 November 2001